News	Events
Publications	Companies
Clinical Trials

Tag Archives: Quark Pharma

• Tony Sedgwick CEO Interview

  0 Replies
  

  May 04, 2012

  Silence Therapeutics CEO, Tony Sedgwick, was interviewed by Brr Media's Cameron Young over 3rd May 2012 announcement that Silence's agreement with partner Pfizer has been extended to develop one of its compounds containing Silence's AtuRNAi. A recording of the interview can be found here: http://www.brrmedia.com/event/97871/anthony-sedgwick-ceo Contine Reading & Discuss→

• Silence’s partner, Quark Pharmaceuticals, extends Pfizer agreement to develop RNAi compound

  0 Replies
  

  May 03, 2012

  Contine Reading & Discuss→